Evidence map›Paper›PMID 9512525›Full record

ArticleNucleic acids research1998

Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.

R V Giles, D G Spiller, J Grzybowski, R E Clark, P Nicklin, D M Tidd

Open access · greenAbstract read
In one paragraph

Article in Nucleic acids research, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 79 citations in OpenAlex.

  1. Review
  2. Article
  3. Nucleic-Acid Structures as Intracellular Probes for Live Cells.Advanced materials (Deerfield Beach, Fla.) · 2020
    Review
  4. Review
  5. Nucleic Acid-Based Nanodevices in Biological Imaging.Annual review of biochemistry · 2016
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK.Molecular therapy : the journal of the American Society of Gene Therapy · 2011
    Article
  11. Article
  12. Article
  13. Article
  14. NANOSTRUCTURED PROBES FOR IN VIVO GENE DETECTION.Nanomedicine : design and applications of magnetic nanomaterials, nanosensors, and nanosystems · 2010
    Article
  15. Fluorescent probes for live-cell RNA detection.Annual review of biomedical engineering · 2009
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

R V GilesSchool of Biological Sciences, University of Liverpool, Life Science Building, Crown Street, Liverpool L69 7ZB, UK. giles@liv.ac.uk
D G Spiller
J Grzybowski
R E Clark
P Nicklin
D M Tidd
University of Liverpool · GBNovartis (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is widely accepted that most cell types efficiently exclude oligonucleotides in vitro and require specific delivery systems, such as cationic lipids, to enhance uptake and subsequent antisense effects. Oligonucleotides are not readily transfected into leukaemia cell lines using cationic lipid systems and streptolysin O (SLO) is used to effect their delivery. We wished to investigate the optimal oligonucleotide composition for antisense efficacy and specificity following delivery into leukaemia cells using SLO. For this study the well characterised chronic myeloid leukaemia cell line KYO-1 was selected and oligonucleotides (20mers) were targeted to an empirically identified accessible site of c- myc mRNA. The efficiency and specificity of antisense effect was measured 4 and 24 h after SLO-mediated delivery of the oligonucleotides. C5-propyne phosphodiester and phosphorothioate compounds were found to present substantial non-specific effects at 20 microM but were inactive at 0.2 microM. Indeed, no antisense-specific effect was noted at any concentration at either time. All of the other oligonucleotides tested induced some measurable antisense effect, except 7 (chimeric, all-phosphorothioate, 2'-methoxyethoxy termini) which was essentially inactive at 20 microM. The rank efficiency order of the remaining antisense compounds was 4 = 3 >> 9 >> 10 = 8 = 5 = 6 > 11. The efficient antisense effects induced by the chimeric methylphosphonate-phosphodiester compounds were found to be highly specific. Increased phosphorothioate content in the oligonucleotide backbone correlated with reduced antisense activity (efficacy: 2'-methoxyethoxy series 9 >> 8 >> 7, 2'-methoxytriethoxy series 10 > 11). No consistent evidence was obtained for increased activity correlating with increased oligonucleotide-mRNA heteroduplex thermal stability. In conclusion, the chimeric methylphosphonate-phosphodiester oligodeoxynucleotides present the most favourable characteristics of the compounds tested, for efficient and specific antisense suppression of gene expression following SLO-mediated delivery.

Indexed as

Genes, mycStreptolysinsBacterial ProteinsBase SequenceCell Membrane PermeabilityCell SurvivalDrug CarriersGene Expression Regulation, NeoplasticHumansKineticsOligodeoxyribonucleotidesOligonucleotides, AntisensePrecursor Cell Lymphoblastic Leukemia-LymphomaRNA, MessengerStructure-Activity RelationshipTransfectionBacterial ProteinsDrug CarriersOligodeoxyribonucleotidesOligonucleotides, AntisenseRNA, Messengerstreptolysin OStreptolysins

Identifiers

PMID9512525
PMCPMC147466
OpenAlexW2033461855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.